Authors: BURGISSER P SPERTINI F WEYRICHSUTER C PAGANI JL MEYLAN PRA

Citation: P. Burgisser et al., MONITORING RESPONSES TO ANTIRETROVIRAL TREATMENT IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED PATIENTS BY SERIAL LYMPH-NODE ASPIRATION, The Journal of infectious diseases, 175(5), 1997, pp. 1202-1205

Authors: BOERLIN P BOERLINPETZOLD F GOUDET J DURUSSEL C PAGANI JL CHAVE JP BILLE J

Citation: P. Boerlin et al., TYPING CANDIDA-ALBICANS ORAL ISOLATES FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS BY MULTILOCUS ENZYME ELECTROPHORESIS AND DNA-FINGERPRINTING, Journal of clinical microbiology, 34(5), 1996, pp. 1235-1248

Authors: BOERLIN P ADDO M BOERLINPETZOLD F DURUSSEL C PAGANI JL CHAVE JP BILLE J

Citation: P. Boerlin et al., TRANSMISSION OF ORAL CANDIDA-ALBICANS STRAINS BETWEEN HIV-POSITIVE PATIENTS, Lancet, 345(8956), 1995, pp. 1052-1053

Authors: BOERLIN P BOERLINPETZOLD F DURUSSEL C ADDO M PAGANI JL CHAVE JP BILLE J

Citation: P. Boerlin et al., CLUSTER OF ORAL ATYPICAL CANDIDA-ALBICANS ISOLATES IN A GROUP OF HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE DRUG-USERS, Journal of clinical microbiology, 33(5), 1995, pp. 1129-1135

Authors: SANGLARD D KUCHLER K ISCHER F PAGANI JL MONOD M BILLE J

Citation: D. Sanglard et al., MECHANISMS OF RESISTANCE TO AZOLE ANTIFUNGAL AGENTS IN CANDIDA-ALBICANS ISOLATES FROM AIDS PATIENTS INVOLVE SPECIFIC MULTIDRUG TRANSPORTERS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2378-2386